SabaMusleh Ud DinMD

Resident

Dr. Musleh Ud Din is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Journal Articles

Risk Factors for 30-Day and 90-Day Readmission in Patients with Tumor Lysis Syndrome: A Nationwide Analysis
Saba Musleh Ud Din, Kyeeun Park, Can Jones, ASH Publication (Blood), 11/5/2024
Unexpected Rasburicase-Induced Hemolysis in a Patient With Normal Glucose-6-Phosphate Dehydrogenase Activity
Saba Musleh Ud Din, Khine Shan, Tauseef Ur Rehman, Stanislav Ivanov, Fernando M. Vargas-Madueno, Journal of Medical Cases, 9/2024
Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer
Saba Musleh Ud Din,Spencer G. Streit,,Bao Tran Huynh,Caroline Hana,Anna-Ninny Abraham, Atif Hussein, International Journal of Molecular Sciences, 2/8/2024

Abstracts/Posters

Incidence of Infections Associated with the Use of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas
Amneh A Fares PharmD 1, Diana Martinez PharmD 1, Saba Musleh Ud Din MD 2, Robert Wilkinson PharmD 1, Julio C Chavez MD 3, Fernando Manuel Vargas Madueno MD 4, Jose San..., Blood (2023) 142 (Supplement 1): 2329., 11/28/2023